NVCR
NovoCure Ltd.
NASDAQ · Healthcare · Medical - Instruments & Supplies · JE
$16.69
−0.18%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 2.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 5.75x
- Price / sales
- 2.78x
- Price / cash flow
- 1300.86x
Enterprise value
- Enterprise value
- $1.7B
- EV / sales
- 2.48x
- EV / EBITDA
- -12.92x
- EV / EBIT
- -11.25x
- Market cap
- $1.9B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026